Could the Pope Give You a Heart Attack?
Those who have been in the presence of the pope often describe the experience as deeply emotional and quite overwhelming. But could these feelings actually cause a heart attack? Probably not—although official studies have not been conducted.
As the devoted prepare for the pilgrimage to Philadelphia next month, the town of Tinicum, PA is preparing for the Papal visit of Pope Francis by outfitting several locations around its town with defibrillators.
The device of choice is the (appropriately named) Samaritan Public Access Defibrillator, which is manufactured by HeartSine Technologies. The product is intended for use during sudden cardiac arrest, as it provides an electrical shock that restores the heart back to normal rhythm. The American Heart Association recommends using both CPR and defibrillation within three to five minutes of the cardiac event.
“With 84% of Sudden Cardiac Arrest incidents taking place outside of the hospital, it is crucial to place AEDs in all public places,” said Pamela Alpin, Sales Manager at HeartSine Technologies, in a news release. While it is important that these potentially life-saving devices are available in public places, proper training is recommended as well. According to Tinicum’s township manager, David Schreiber, the town selected the Samaritan device because it walks the user through the process of employing the AED.
Related Articles
-
A global pandemic is still upon us, but that certainly does not mean that healthcare technology innovation is standing still. To help the medical device industry look to the future and prepare, experts from regulation and academia alike are bringing…
-
The draft guidance proposes updates to clarify how the Breakthrough Devices Program may be applicable to certain medical devices that promote health equity, as well as considerations in designating eligible devices that may benefit populations impacted by disparities in health…
-
The research team used focused rotary jet spinning to create polymeric materials that were then seeded with cardiomyocytes to create a biohybrid model of human ventricles with helically aligned beating cardiac cells.
-
New data presented at the Technology and Heart Failure Therapeutics (THT) Conference showed that hemodynamic monitoring can slow the progression of heart failure in patients with reduced ejection fraction.
